Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 13 of 13 for “"Nanotherapy"”.

  1. Development of a novel targeted nanotherapy for the treatment of melanoma

    Nanoparticles have been utilised in a wide range of applications and they provide unique advantages as drug delivery carriers and imaging agents in biomedicine. In particular, nanoparticles have been employed as therapeutic systems in oncology to overcome the limitations of conventional …

    east-anglia Download PDF for Development of a novel targeted nanotherapy for the treatment of melanoma (opens in a new tab)

  2. Evaluation of drug-loaded gold nanoparticle cytotoxicity as a function of tumor tissue heterogeneity.

    … gold nanoparticles loaded with cisplatin, nanotherapy is simulated with different levels of tissue heterogeneity, and the treatment response is measured in terms of tumor regression. The results show that tumor vascular density non-trivially influences the nanoparticle uptake and washout, …

    louisville Repository record for Evaluation of drug-loaded gold nanoparticle cytotoxicity as a function of tumor tissue heterogeneity. (opens in a new tab)

  3. Colloidal gold nanoparticles for cancer therapy: effects of particle size on treatment efficacy, toxicology, and biodistribution

    … biodistribution, and clearance in cancer nanotherapy. We believe that nanoparticle size plays a critical role in not only delivering the drug to the target site but also determining the in vivo behavior such as biodistribution and clearance. By choosing an appropriate size scale for the …

    gatech Repository record for Colloidal gold nanoparticles for cancer therapy: effects of particle size on treatment efficacy, toxicology, and biodistribution (opens in a new tab)

  4. Nanocarriers for the Targeted Delivery of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to Tumours

    … This work aimed at employing the principles of nanotherapy to maximise the benefits of NSAIDs and minimise the risks of their harmful side effects. By exploiting the enhanced permeability and retention effect (EPR) unique to inflammatory tissues, NSAID-loaded nanocarriers could deliver high …

    kent Download PDF for Nanocarriers for the Targeted Delivery of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to Tumours (opens in a new tab)

  5. Synthesis, characterization and applications of peptide-coated nanoparticles

    … 25% of patients survive the five years mark. Nanotherapy provides significant and unique benefits for drug efficacy, as nanoparticles (NPs) can increase the solubility, bioavailability, and permeability of many potent drugs. Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful …

    cuny-grad Repository record for Synthesis, characterization and applications of peptide-coated nanoparticles (opens in a new tab)

  6. UNDERSTANDING NANOPARTICLE-CELL INTERACTION

    … (gene and drug delivery, imaging, sensing, nanotherapy) and implications (toxicity) of nanomaterials, mostly within the context of biological systems. In addition, this chapter documents theendocytotic and exocytotic pathways of the cell, and reviews the state-of-the-art of our understanding …

    clemson Repository record for UNDERSTANDING NANOPARTICLE-CELL INTERACTION (opens in a new tab)

  7. Blunting Colitis by Targeting Gut Microbial Antigen-Loaded Antigen-Presenting Cells

    The non-obese diabetic (NOD) mouse is commonly used for studying type-1 diabetes (T1D). Among many β-cell auto-antigens (Ags), the Santamaria lab has focused on understanding the role of the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) in T1D pathogenesis. In NOD …

    calgary Repository record for Blunting Colitis by Targeting Gut Microbial Antigen-Loaded Antigen-Presenting Cells (opens in a new tab)

  8. Regulation and Function of Integrin β3 in Bone-Metastatic Breast Cancer Cells in the Therapeutic Setting

    Breast cancer is the most common non-cutaneous malignancy in women, with over 250,000 patients diagnosed each year in the United States alone. The bone is the most common site of recurrence in breast cancer, affecting over two-thirds of patients with metastatic disease and presenting as the only …

    wustl Repository record for Regulation and Function of Integrin β3 in Bone-Metastatic Breast Cancer Cells in the Therapeutic Setting (opens in a new tab)

  9. Orally Administered Nanoscale Drug Delivery System for Colorectal Cancer

    Mithramycin-A (Mit-A) is a US Food and Drug Administration (FDA) approved chemotherapeutic agent that is used for the treatment of testicular cancer. According to previous studies, Mit-A has shown promising results in targeting colorectal cancer (CRC) and cancer stem cells (CSCs) which are …

    usf Repository record for Orally Administered Nanoscale Drug Delivery System for Colorectal Cancer (opens in a new tab)

  10. Enhanced penetration of lipid functionalized nanoparticles in 3D cell cultures.

    Nanoparticle-based systems can alleviate systemic toxicity via surface functionalization to promote tissue-specific targeting as well as passive targeting abilities [1], such as the enhanced permeation and retention effect (EPR) [2]. The transport of nanoparticles is limited in hypoxic tumor …

    louisville Repository record for Enhanced penetration of lipid functionalized nanoparticles in 3D cell cultures. (opens in a new tab)

  11. ADVANCING TREATMENT FOR TRIPLE-NEGATIVE BREAST CANCER: INTEGRATING PHOTOTHERMAL THERAPY WITH IMMUNOMODULATION IN A PRECLINICAL MODEL

    Triple-negative breast cancer (TNBC) is an aggressive and highly metastatic form of breast cancer with limited treatment options and poor long-term outcomes. Even when the primary tumor is controlled, relapse, metastatic spread, and treatment resistance remain major challenges. Therefore, there is …

    oklahoma-thes Repository record for ADVANCING TREATMENT FOR TRIPLE-NEGATIVE BREAST CANCER: INTEGRATING PHOTOTHERMAL THERAPY WITH IMMUNOMODULATION IN A PRECLINICAL MODEL (opens in a new tab)

  12. The development and characterisation of MicroRNA and gemcitabine nanotherapies for the treatment of pancreatic cancer

    Pancreatic cancer has been considered as the most lethal cancer type among adults for many decades. Especially with the failure to improve survival rates for the last 40 years, despite all the progress in targeting therapies. With the lack of therapeutic options, attention has been directed towards …

    qu-belfast Repository record for The development and characterisation of MicroRNA and gemcitabine nanotherapies for the treatment of pancreatic cancer (opens in a new tab) Embargoed until 2027-07-31